Genetic Counseling for Frontotemporal Dementias

被引:0
|
作者
Kimberly A. Quaid
机构
[1] Indiana University School of Medicine,Department of Medical and Molecular Genetics
来源
关键词
Frontotemporal dementia; Genetic counseling;
D O I
暂无
中图分类号
学科分类号
摘要
Frontotemporal dementia (FTD) is an umbrella term for a heterogeneous group of neurodegenerative disorders that are characterized by changes in cognition, language, personality, and social functioning. Approximately 40% of individuals with FTD have a family history of dementia, but less than 10% have a clear autosomal dominant pattern of inheritance. However, establishing a clear mode of inheritance in FTD is complicated by clinical heterogeneity, variable expression, phenocopies, misdiagnosis, early death due to other causes, missing medical records, and lost family histories. Mutations in the microtubule-associated protein tau and progranulin genes have been reported in the majority of hereditary cases, making genetic testing of at-risk individuals possible. The first step in counseling a family with a history of FTD is to take a comprehensive family history with confirmation of any diagnosis in a family member with medical records to the extent possible. If the pedigree analysis suggests an autosomal dominant pattern of inheritance, genetic testing of an affected relative may be offered to the family to determine if a mutation is present. If a mutation is found, relatives interested in pursuing genetic testing should be referred to a genetic counselor familiar with genetic testing for neurodegenerative disorders. Predictive testing of unaffected and at-risk relatives should only be offered in the context of a comprehensive genetic counseling protocol offering pre- and post-test counseling and support. One survey of at-risk individuals in a large family with FTD found that 50% were interested in testing. In one study actually offering genetic testing for FTD, the rate of uptake of testing was only 8.4%. A more recent study estimated the uptake for testing for FTD to be somewhere between 7% and 17% and attributed the low uptake to family resistance to testing. While genetic testing may be appropriate for some families with Alzheimer's disease and FTD, uptake of testing may be expected to be low.
引用
收藏
页码:706 / 709
页数:3
相关论文
共 50 条
  • [31] The functional neuroanatomy of emotion processing in frontotemporal dementias
    Marshall, Charles R.
    Hardy, Christopher J. D.
    Russell, Lucy L.
    Bond, Rebecca L.
    Sivasathiaseelan, Harri
    Greaves, Caroline
    Moore, Katrina M.
    Agustus, Jennifer L.
    van Leeuwen, Janneke E. P.
    Wastling, Stephen J.
    Rohrer, Jonathan D.
    Kilner, James M.
    Warren, Jason D.
    [J]. BRAIN, 2019, 142 : 2873 - 2887
  • [32] Alzheimer disease and frontotemporal dementias - Behavioral distinctions
    Levy, ML
    Miller, BL
    Cummings, JL
    Fairbanks, LA
    Craig, A
    [J]. ARCHIVES OF NEUROLOGY, 1996, 53 (07) : 687 - 690
  • [33] Molecular and neuropathological characterization of the frontotemporal dementias.
    Hulette, CM
    Ervin, JE
    Trojanowski, JQ
    Lee, VM
    Forman, M
    Schmechel, DE
    Vance, JM
    Wang, D
    Corral, A
    Hutton, M
    Dickson, DW
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (05): : 513 - 513
  • [34] Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias
    Clémence Fournier
    Vincent Anquetil
    Agnès Camuzat
    Sandrine Stirati-Buron
    Véronique Sazdovitch
    Laura Molina-Porcel
    Sabrina Turbant
    Daisy Rinaldi
    Raquel Sánchez-Valle
    Mathieu Barbier
    Morwena Latouche
    Giovanni Stevanin
    Danielle Seilhean
    Alexis Brice
    Charles Duyckaerts
    Isabelle Le Ber
    [J]. Acta Neuropathologica Communications, 6
  • [35] Clinical and psychometric distinction of frontotemporal and Alzheimer dementias
    Liscic, Rajka M.
    Storandt, Martha
    Cairns, Nigel J.
    Morris, John C.
    [J]. ARCHIVES OF NEUROLOGY, 2007, 64 (04) : 535 - 540
  • [36] Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias
    Fournier, Clemence
    Anquetil, Vincent
    Camuzat, Agnes
    Stirati-Buron, Sandrine
    Sazdovitch, Veronique
    Molina-Porcel, Laura
    Turbant, Sabrina
    Rinaldi, Daisy
    Sanchez-Valle, Raquel
    Barbier, Mathieu
    Latouche, Morwena
    Stevanin, Giovanni
    Seilhean, Danielle
    Brice, Alexis
    Duyckaerts, Charles
    Le Ber, Isabelle
    [J]. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2018, 6
  • [37] Interrupted CAG repeats in ATXN2 gene: an expansion of the genetic spectrum of frontotemporal dementias
    Fournier, C.
    Anquetil, V.
    Camuzat, A.
    Stirati-Buron, S.
    Barbier, M.
    Sazdovitch, V.
    Turbant, S.
    Stevanin, G.
    Seilhean, D.
    Brice, A.
    Duyckaerts, C.
    Le Ber, I.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 194 - 194
  • [38] Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias
    Mott, RT
    Dickson, DW
    Trojanowski, JQ
    Zhukareva, V
    Lee, VM
    Forman, M
    Van Deerlin, V
    Ervin, JF
    Wang, DS
    Schmechel, DE
    Hulette, CM
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (05): : 420 - 428
  • [39] Frontotemporal dementias: Recent advances and current controversies
    Leyton, Cristian E.
    Hodges, John R.
    [J]. ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2010, 13 : 74 - 80
  • [40] New Approaches to Genetic Counseling and Testing for Alzheimer’s Disease and Frontotemporal Degeneration
    Jill S. Goldman
    [J]. Current Neurology and Neuroscience Reports, 2012, 12 : 502 - 510